Who
Sanjiv Patel
President and CEO
Company insider
Files Form 4 as: President and CEO, Relay Therapeutics; Director, Prothena Corporation.
In numbers
- Trades disclosed
- 112
- Buys
- 1
- Sells
- 33
- Bought
- $500K
- Sold
- $19.9M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 20 Jul 2020
- Last trade
- 7 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Oct 2026filed 8 Oct 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $872K48,199 at $18.10 | filing |
| 8 Sep 2026filed 9 Sep 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $913K48,199 at $18.94 | filing |
| 8 Sep 2026filed 9 Sep 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $913K48,199 at $18.94 | filing |
| 17 Aug 2026filed 18 Aug 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $980K48,199 at $20.33 | filing |
| 17 Aug 2026filed 18 Aug 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $980K48,199 at $20.33 | filing |
| 7 Jul 2026filed 8 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $944K48,199 at $19.58 | filing |
| 7 Jul 2026filed 8 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $944K48,199 at $19.58 | filing |
| 30 Jun 2026filed 8 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $21K3,056 at $6.95 | filing |
| 30 Jun 2026filed 8 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $21K3,056 at $6.95 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,450,000 at $0.00 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,450,000 at $0.00 | filing |
| 6 Jan 2026filed 7 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $338K43,168 at $7.82 | filing |
| 6 Jan 2026filed 7 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $338K43,168 at $7.82 | filing |
| 31 Dec 2025filed 7 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,972994 at $2.99 | filing |
| 31 Dec 2025filed 7 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,972994 at $2.99 | filing |
| 3 Nov 2025filed 4 Nov 2025 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $435K62,073 at $7.00 | filing |
| 9 Jul 2025filed 10 Jul 2025 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $153K42,740 at $3.57 | filing |
| 9 Jul 2025filed 10 Jul 2025 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $67K18,639 at $3.57 | filing |
| 30 Jun 2025filed 1 Jul 2025 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K5,000 at $2.94 | filing |
| 23 Apr 2025filed 24 Apr 2025 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $127K42,769 at $2.97 | filing |
News
Relay Therapeutics (NASDAQ:RLAY) Stock: Insider Sanjiv Patel Sells 48,199 Sharesdailypolitical.com · 8 Oct 2026Head-To-Head Comparison: Krystal Biotech (NASDAQ:KRYS) and Relay Therapeutics (NASDAQ:RLAY)RLAY · tickerreport.com · 11 Oct 2026
1 headline in the last 90 days name Sanjiv Patel; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.